We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VENUSREM.NSE

Price
305.85
Stock movement up
+7.45 (2.50%)
Company name
Venus Remedies Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
4.09B
Ent value
4.97B
Price/Sales
0.67
Price/Book
0.83
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
18.50
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-12.40%
3 year return
5.13%
5 year return
59.75%
10 year return
5.84%
Last updated: 2025-04-15

DIVIDENDS

VENUSREM.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E18.50
Price to OCF31.26
Price to FCF31.26
Price to EBITDA33.96
EV to EBITDA41.25

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.67
Price to Book0.83
EV to Sales0.81

FINANCIALS

Per share

Per share data
Current share count13.37M
EPS (TTM)16.56
FCF per share (TTM)9.80

Income statement

Income statement data
Revenue (TTM)6.15B
Gross profit (TTM)1.38B
Operating income (TTM)228.60M
Net income (TTM)221.00M
EPS (TTM)16.56
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)22.52%
Operating margin (TTM)3.72%
Profit margin (TTM)3.60%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash784.30M
Net receivables825.60M
Total current assets3.91B
Goodwill0.00
Intangible assets1.10B
Property, plant and equipment1.50B
Total assets6.60B
Accounts payable634.10M
Short/Current long term debt409.10M
Total current liabilities1.01B
Total liabilities1.66B
Shareholder's equity4.94B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)130.80M
Capital expenditures (TTM)0.00
Free cash flow (TTM)130.80M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity4.47%
Return on Assets3.35%
Return on Invested Capital4.13%
Cash Return on Invested Capital2.44%

STOCK INFORMATION

Stock chart

Stock price data
Open300.75
Daily high309.00
Daily low300.75
Daily Volume12K
All-time high611.45
1y analyst estimate-
Beta1.06
EPS (TTM)16.56
Dividend per share-
Ex-div date23 Sep 2013
Next earnings date-

Downside potential

Downside potential data
VENUSREM.NSES&P500
Current price drop from All-time high-49.98%-12.89%
Highest price drop-96.67%-56.47%
Date of highest drop9 Oct 20199 Mar 2009
Avg drop from high-62.61%-11.07%
Avg time to new high216 days12 days
Max time to new high3364 days1805 days
COMPANY DETAILS
VENUSREM.NSE (Venus Remedies Limited) company logo
Marketcap
4.09B
Marketcap category
Mid-cap
Description
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
Employees
1187
Website
https://www.venusremedies.com
Investor relations
-
SEC filings
VENUSREM.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved